Rising awareness of obesity-related risks further boosts uptake
Bnh mch vnh, au tht ngc: Truyn tnh mch t 1200-3000 mg/ ngy
Management strategies include maintaining excellent oral hygiene, staying well-hydrated throughout the day, stimulating saliva flow with sugar-free gum or candies, using alcohol-free mouthwash, and addressing potential gastroesophageal reflux
Peak VO 2 improvement was not supported by the pharmacokinetic/pharmacodynamic modelling, indicating no relationship between exposure to albiglutide and peak VO 2
While a causal relationship remains inconclusive (patients with T2D and obesity have other pancreatitis risk factors), prudence dictates avoiding these drugs in patients with a history of pancreatitis or at least using with caution
Tirzepatide Titration: typically starts at 2.5mg, then 5mg, 7.5mg, up to 15mg weekly